- Home
- YETI vs IOVA Comparison
YETI vs IOVA Comparison
Compare YETI & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YETI
- IOVA
- Stock Information
- Founded
- YETI 2006
- IOVA 2007
- Country
- YETI United States
- IOVA United States
- Employees
- YETI N/A
- IOVA N/A
- Industry
- YETI Recreational Games/Products/Toys
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YETI Consumer Discretionary
- IOVA Health Care
- Exchange
- YETI Nasdaq
- IOVA Nasdaq
- Market Cap
- YETI 3.2B
- IOVA 2.6B
- IPO Year
- YETI 2018
- IOVA N/A
- Fundamental
- Price
- YETI $36.91
- IOVA $5.61
- Analyst Decision
- YETI Hold
- IOVA Strong Buy
- Analyst Count
- YETI 13
- IOVA 9
- Target Price
- YETI $45.00
- IOVA $23.06
- AVG Volume (30 Days)
- YETI 1.9M
- IOVA 7.2M
- Earning Date
- YETI 02-13-2025
- IOVA 02-26-2025
- Dividend Yield
- YETI N/A
- IOVA N/A
- EPS Growth
- YETI 5.67
- IOVA N/A
- EPS
- YETI 2.05
- IOVA N/A
- Revenue
- YETI $1,829,873,000.00
- IOVA $90,858,000.00
- Revenue This Year
- YETI $9.68
- IOVA $13,803.28
- Revenue Next Year
- YETI $7.52
- IOVA $167.55
- P/E Ratio
- YETI $18.00
- IOVA N/A
- Revenue Growth
- YETI 10.32
- IOVA 12751.20
- 52 Week Low
- YETI $33.41
- IOVA $5.05
- 52 Week High
- YETI $45.25
- IOVA $18.33
- Technical
- Relative Strength Index (RSI)
- YETI 44.91
- IOVA 40.15
- Support Level
- YETI $36.35
- IOVA $5.44
- Resistance Level
- YETI $40.59
- IOVA $5.80
- Average True Range (ATR)
- YETI 1.55
- IOVA 0.32
- MACD
- YETI 0.10
- IOVA 0.06
- Stochastic Oscillator
- YETI 27.56
- IOVA 50.45
About YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.